abrdn plc boosted its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 944,205 shares of the financial services provider's stock after buying an additional 21,414 shares during the period. abrdn plc owned 0.14% of MetLife worth $77,293,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in MET. MeadowBrook Investment Advisors LLC raised its holdings in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock valued at $26,000 after buying an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its holdings in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after buying an additional 186 shares during the period. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. purchased a new stake in shares of MetLife during the 3rd quarter valued at about $30,000. Finally, Retirement Wealth Solutions LLC purchased a new stake in shares of MetLife during the 4th quarter valued at about $32,000. 94.99% of the stock is owned by institutional investors and hedge funds.
MetLife Stock Performance
NYSE:MET traded up $0.29 during midday trading on Wednesday, reaching $84.92. 5,285,281 shares of the company traded hands, compared to its average volume of 3,553,012. MetLife, Inc. has a twelve month low of $65.65 and a twelve month high of $89.05. The firm has a market capitalization of $58.80 billion, a price-to-earnings ratio of 17.12, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The company has a fifty day moving average price of $83.96 and a 200 day moving average price of $80.68.
MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 5.27% and a return on equity of 20.01%. On average, analysts expect that MetLife, Inc. will post 8.18 EPS for the current fiscal year.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.57%. MetLife's dividend payout ratio is currently 43.95%.
Analysts Set New Price Targets
Several equities research analysts recently commented on the company. Barclays raised their target price on MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a report on Monday, January 6th. TD Cowen lifted their price objective on MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a report on Wednesday, November 27th. Wells Fargo & Company dropped their price objective on MetLife from $93.00 to $92.00 and set an "overweight" rating on the stock in a report on Tuesday, January 14th. BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price objective on the stock. Finally, JPMorgan Chase & Co. lifted their price objective on MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a report on Tuesday, January 7th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, MetLife has an average rating of "Moderate Buy" and an average price target of $90.46.
Get Our Latest Research Report on MetLife
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
![Institutional Ownership by Quarter for MetLife (NYSE:MET)](https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&Symbol=MET)
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.